1.
J Biopharm Stat
; 24(6): 1154-64, 2014.
Artículo
en Inglés
| MEDLINE
| ID: mdl-25036475
RESUMEN
Recent progress in biosimilars development is overviewed, with attention to the history of issues and processes leading to current regulations, and to scientific considerations, including progress on design and operational implementation issues that arise and are peculiar to biosimilars trial design and implementation.